Privia Health Group saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 75 to 82.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's unique rating measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the trailing 52 weeks compares to all the other stocks in our database.
Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating of at least 80 as they launch their biggest price moves.
Privia Health Group is building a consolidation with a 26.09 entry. See if it can clear the breakout price in volume at least 40% above average.
Earnings growth slowed last quarter from 40% to 22%. But sales moved higher, from 5% to 16%.
The company holds the No. 5 rank among its peers in the Computer Software-Medical industry group. Veeva Systems Cl A is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
